Herpes Labialis: Clinical Trials

14 trials for Herpes Labialis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 completed, 1 unknown. 14 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 314Completed 13, Unknown 1
Phase 21Completed 1

Follow Herpes Labialis: new trials by email Literature Review of Herpes Labialis trials Research Report on Herpes Labialis

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants Whose Immune System Works Normally
Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773, Placebo - Recurrent Herpes Labialis
Phase 3CompletedBayer20202021-11-232025-09-02
Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis
Acyclovir 5 percent (Perrigo), Acyclovir 5 percent (Reference), Placebo cream - Herpes Labialis
Phase 3CompletedPadagis LLC40762014-10-062021-10-22
NB-001 Treatment of Recurrent Herpes Labialis
NB-001 (0.3%), Placebo - Herpes Labialis
Phase 3UnknownNanoBio Corporation3622012-10-012013-06-14
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
acyclovir/hydrocortisone cream - Herpes Labialis
Phase 3CompletedMeda Pharmaceuticals542012-03-012014-05-22
Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis
Acyclovir 50mg/g, Penciclovir 10mg/g - Herpes Labialis
Phase 3CompletedEMS762012-02-012013-03-04
A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)
NB-001, Vehicle - Recurrent Herpes Labialis
Phase 3CompletedNanoBio Corporation8472011-04-012013-05-23
A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis
Vehicle versus NB-001 - Recurrent Herpes Simplex Labialis
Phase 3CompletedNanoBio Corporation9072011-04-012013-05-23
Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
Famciclovir - Herpes Labialis
Phase 2 / Phase 3CompletedNovartis Pharmaceuticals532009-03-252021-06-25
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Zicam (Ionic zinc), placebo - Herpes Simplex Labialis
Phase 3CompletedIntegrative Medicine Institute1572008-12-012014-01-08
Phase 3 Clinical Study for the Treatment of Cold Sore
Acyclovir Lauriad, Placebo - Herpes Labialis
Phase 3CompletedValerio Therapeutics17272007-05-012012-12-21
Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients
ME-609, Acyclovir in ME-609 vehicle (5% acyclovir) - Herpes Labialis
Phase 3CompletedMedivir2012006-12-012008-08-15
Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents
ME-609 - Herpes Labialis
Phase 3CompletedMedivir2542006-10-012008-08-18
Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis
ME-609, acyclovir in ME-609 vehicle, Vehicle - Herpes Labialis
Phase 3CompletedMedivir14432006-07-012008-08-18
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
Famciclovir - Herpes Simplex
Phase 3CompletedNovartis Pharmaceuticals742005-02-012013-04-25

Narrower conditions

Herpes Simplex (3)

Broader conditions

DNA Virus Infections (14)  ·  Herpesviridae Infections (14)  ·  Infections (14)  ·  Lip Diseases (14)  ·  Mouth Diseases (14)  ·  Skin Diseases (14)  ·  Skin Diseases, Infectious (14)  ·  Skin Diseases, Viral (14)  ·  Skin and Connective Tissue Diseases (14)  ·  Stomatognathic Diseases (14)  ·  Virus Diseases (14)  ·  Herpes Simplex (11)

Interventions

Acyclovir (5)  ·  ME 609 (3)  ·  5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol (2)  ·  Famciclovir (2)  ·  Tablets (1)  ·  penciclovir (1)

Sponsors

Medivir (3)  ·  NanoBio Corporation (3)  ·  Novartis Pharmaceuticals (2)  ·  Bayer (1)  ·  EMS (1)  ·  Integrative Medicine Institute (1)  ·  Meda Pharmaceuticals (1)  ·  Padagis LLC (1)  ·  Valerio Therapeutics (1)

Countries

United States (11)  ·  Australia (1)  ·  Brazil (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Panama (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Anders Strand, MD PhD (1)  ·  Christopher M Hull, MD (1)  ·  David Ginsburg, D.O. (1)  ·  David S Riley, MD (1)  ·  Flavia Addor, MD (1)

Results publications

PMID 19273678, PMID 20851499, PMID 21178655